Trial reportJournal of rehabilitation medicine2025
The Borg scale is safe and efficacious for prescribing and monitoring self-administered balance and resistance exercise in patients with chronic kidney disease: a post-hoc analysis of RENEXC, a randomized controlled trial.
Trial report in Journal of rehabilitation medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the safety, adherence, and efficacy of self-administered balance and resistance exercise using the Borg scale in patients with chronic kidney disease, and to examine relationships between exercise intensity or duration and baseline measures, and relationships between change in physical performance and baseline measures, intensity, or duration.
designPost-hoc analysis of a randomized controlled trial. PATIENTS: 151 patients, mean age 66 (14) years, measured glomerular filtration rate 22 (8) mL/min/1.73 m2.
methods12 months balance or resistance exercise, Borg 13-17, combined with aerobic exercise. Berg Balance scale, Functional Reach, isometric quadriceps strength and 30 s sit-to-stand were assessed at baseline and after 12 months. Intensity and duration were recorded in an exercise diary.
resultsNo injuries occurred. Patients reported high adherence, median intensity 14 (13-15). Both groups maintained/improved physical performance by 2-18%, within a wide duration, mean 56 (range 3-194) min/week. No significant relationships were found between intensity or duration and baseline measures, or between improved physical performance and baseline measures, intensity, or duration.
conclusionTwelve months' self-administered balance and resistance exercise were safe and adhered to, using the Borg scale, in patients with chronic kidney disease. Physical performance improved, showing that even short weekly durations can be efficacious when prescribed intensity is maintained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.